Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
3284 | 1942 | 40.4 | 69% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1857 | 5546 | PROLACTIN//PROLACTIN RECEPTOR//PHOSPHORYLATED PROLACTIN |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | PROLACTIN RECEPTOR | Author keyword | 69 | 42% | 6% | 126 |
2 | PHOSPHORYLATED PROLACTIN | Author keyword | 27 | 92% | 1% | 11 |
3 | PROLACTIN RECEPTORS | Author keyword | 18 | 53% | 1% | 23 |
4 | 16K PROLACTIN | Author keyword | 15 | 88% | 0% | 7 |
5 | GLYCOSYLATED PROLACTIN | Author keyword | 15 | 88% | 0% | 7 |
6 | PROLACTIN ANTAGONIST | Author keyword | 14 | 100% | 0% | 7 |
7 | EQUIPE PHYSIOPATHOL HORMONES PRL GH | Address | 11 | 100% | 0% | 6 |
8 | S179D PROLACTIN | Author keyword | 11 | 100% | 0% | 6 |
9 | INSERM U344 | Address | 11 | 43% | 1% | 19 |
10 | HUMAN PROLACTIN RECEPTOR | Author keyword | 9 | 83% | 0% | 5 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PROLACTIN RECEPTOR | 69 | 42% | 6% | 126 | Search PROLACTIN+RECEPTOR | Search PROLACTIN+RECEPTOR |
2 | PHOSPHORYLATED PROLACTIN | 27 | 92% | 1% | 11 | Search PHOSPHORYLATED+PROLACTIN | Search PHOSPHORYLATED+PROLACTIN |
3 | PROLACTIN RECEPTORS | 18 | 53% | 1% | 23 | Search PROLACTIN+RECEPTORS | Search PROLACTIN+RECEPTORS |
4 | 16K PROLACTIN | 15 | 88% | 0% | 7 | Search 16K+PROLACTIN | Search 16K+PROLACTIN |
5 | GLYCOSYLATED PROLACTIN | 15 | 88% | 0% | 7 | Search GLYCOSYLATED+PROLACTIN | Search GLYCOSYLATED+PROLACTIN |
6 | PROLACTIN ANTAGONIST | 14 | 100% | 0% | 7 | Search PROLACTIN+ANTAGONIST | Search PROLACTIN+ANTAGONIST |
7 | S179D PROLACTIN | 11 | 100% | 0% | 6 | Search S179D+PROLACTIN | Search S179D+PROLACTIN |
8 | HUMAN PROLACTIN RECEPTOR | 9 | 83% | 0% | 5 | Search HUMAN+PROLACTIN+RECEPTOR | Search HUMAN+PROLACTIN+RECEPTOR |
9 | PROLACTIN HETEROGENEITY | 9 | 83% | 0% | 5 | Search PROLACTIN+HETEROGENEITY | Search PROLACTIN+HETEROGENEITY |
10 | PROLACTIN RECEPTOR ANTAGONIST | 8 | 75% | 0% | 6 | Search PROLACTIN+RECEPTOR+ANTAGONIST | Search PROLACTIN+RECEPTOR+ANTAGONIST |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CLEAVED PROLACTIN | 53 | 85% | 1% | 28 |
2 | PRL RECEPTOR | 48 | 53% | 3% | 64 |
3 | 16 KDA PROLACTIN | 44 | 100% | 1% | 16 |
4 | PHOSPHORYLATED PROLACTIN | 35 | 81% | 1% | 21 |
5 | NODE LYMPHOMA CELLS | 32 | 78% | 1% | 21 |
6 | HPRL G129R | 30 | 100% | 1% | 12 |
7 | UNMODIFIED PROLACTIN | 26 | 87% | 1% | 13 |
8 | 16K FORMS | 23 | 100% | 1% | 10 |
9 | HUMAN PRL RECEPTORS | 23 | 100% | 1% | 10 |
10 | RABBIT MAMMARY GLAND | 21 | 59% | 1% | 24 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Prolactin (PRL) and its receptor: Actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice | 1998 | 909 | 515 | 34% |
New concepts in prolactin biology | 2010 | 58 | 83 | 71% |
What can we learn from rodents about prolactin in humans? | 2008 | 196 | 376 | 37% |
Molecular Mechanisms of Prolactin and Its Receptor | 2012 | 29 | 145 | 54% |
Development and potential clinical uses of human prolactin receptor antagonists | 2005 | 106 | 146 | 73% |
The role of prolactin in mammary carcinoma | 2003 | 284 | 266 | 42% |
Prolactin: The new biology of an old hormone | 2002 | 192 | 110 | 62% |
Minireview: Extrapituitary Prolactin: An Update on the Distribution, Regulation, and Functions | 2014 | 10 | 95 | 46% |
Prolactin and Human Tumourogenesis | 2010 | 27 | 54 | 70% |
Prolactin and adipose tissue | 2014 | 11 | 46 | 35% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | EQUIPE PHYSIOPATHOL HORMONES PRL GH | 11 | 100% | 0.3% | 6 |
2 | INSERM U344 | 11 | 43% | 1.0% | 19 |
3 | MALAD RA GYNECOL | 6 | 100% | 0.2% | 4 |
4 | EQUIPE PRL GH TUMEURS | 4 | 75% | 0.2% | 3 |
5 | U808 | 4 | 75% | 0.2% | 3 |
6 | UNIT 808 | 4 | 75% | 0.2% | 3 |
7 | UNITE ENDOCRINOL MOLEC | 4 | 75% | 0.2% | 3 |
8 | U584 | 4 | 33% | 0.5% | 10 |
9 | U344 | 4 | 27% | 0.7% | 13 |
10 | SECT MOL ENDOCRINOL | 4 | 25% | 0.7% | 13 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000205697 | ENDOMETRIAL PROLACTIN//RECURRENT POLYHYDRAMNIOS//PGHS2 |
2 | 0.0000181924 | EDWARD R MADIGAN 207//BIOACTIVE PROLACTIN//THYMUS |
3 | 0.0000122847 | METAB REGULAT GRP//CLIN MULTIIMAGEM//PITUITARY ADENOMA GUANGDONG PROV |
4 | 0.0000110791 | 20K HGH//22K HGH//GH ABUSE |
5 | 0.0000104440 | LARON SYNDROME//GROWTH HORMONE RECEPTOR//GROWTH HORMONE INSENSITIVITY |
6 | 0.0000101966 | TIDA NEURON//TUBEROINFUNDIBULAR DOPAMINE NEURONS//TUBEROINFUNDIBULAR NEURONS |
7 | 0.0000097198 | ENDOCRINOL SERV MARTIN LAGOS SN//BHX 511//BIOSIGNAL MOL CELLULAR REGULAT |
8 | 0.0000088487 | LH HCG RECEPTOR//RAT PSEUDOPREGNANCY//LH HCG RECEPTORS |
9 | 0.0000069935 | BENIGN MASTOPATHIES//PRIMARY HUMAN BREAST CANCER//BOVINE MAMMARY CELLS |
10 | 0.0000069351 | CANC DEV BIOL MATERNAL FETAL BIOL//PROLIFERIN//CS MOTT HUMAN GROWTH |